about
Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis.Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1)MicroRNA-24 regulates macrophage behavior and retards atherosclerosisGenetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in miceMMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis.Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.Relationship of MMP-14 and TIMP-3 expression with macrophage activation and human atherosclerotic plaque vulnerability.Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κBClassical and Alternative Activation and Metalloproteinase Expression Occurs in Foam Cell Macrophages in Male and Female ApoE Null Mice in the Absence of T and B Lymphocytes.A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice.Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient micecAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.The anti-atherogenic cytokine interleukin-33 inhibits the expression of a disintegrin and metalloproteinase with thrombospondin motifs-1, -4 and -5 in human macrophages: Requirement of extracellular signal-regulated kinase, c-Jun N-terminal kinase aEC4, a truncation of soluble N-cadherin, reduces vascular smooth muscle cell apoptosis and markers of atherosclerotic plaque instability.Cathepsin K Deficiency Prevents the Aggravated Vascular Remodeling Response to Flow Cessation in ApoE-/- Mice.Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasionCarotid atherosclerotic plaque matrix metalloproteinase-12-positive macrophage subpopulation predicts adverse outcome after endarterectomy.Assessment of unstable atherosclerosis in mice.Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.MicroRNA-181b Controls Atherosclerosis and Aneurysms Through Regulation of TIMP-3 and Elastin.Macrophage heterogeneity in atherosclerotic plaques.Functional and cardioprotective effects of simultaneous and individual activation of protein kinase A and Epac.Role of colony-stimulating factors in atherosclerosis.Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis.Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages.Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability.Wnt2 and WISP-1/CCN4 Induce Intimal Thickening via Promotion of Smooth Muscle Cell Migration.TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice.In situ zymography.Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein.Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice.Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis.An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs.A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening.Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid.Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy.Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein.
P50
Q27343116-7F0002CF-A777-4A4D-A6C5-B57ACB053E22Q28222299-358A213F-9A20-4B52-8651-90D0CB94262AQ28591606-6E2108FA-E1C4-4295-B248-A43E2C62F5C9Q30429015-24A7AB31-8A2C-45E3-8116-112AE8374ACDQ33906860-4B4D1A20-4C77-424E-9BAF-92C5722E46CFQ34098485-399C5BD1-EBD5-4155-9551-AF707D708165Q34175955-D49146DA-5FF5-4942-B9C0-78E5151EEB5FQ34374198-9D6B5163-9633-417B-A2AF-6186DFBBD4C3Q34413984-D464DC48-42BD-4C86-8F94-6BC5EF1FBABEQ34585560-4762F6B0-9461-4B6C-BCB3-114F9E099763Q34735060-126A3BE9-CC4D-475E-9092-DBD1C71CF884Q35033109-7E14518F-F6D6-4723-B0EF-B77377219A2EQ35052649-4DB8D78F-697C-4C84-B47A-5D5DAC5D5FF6Q35184213-E8E0A9FB-4933-4CA0-BE39-1507643AF01BQ36135704-B4E6614E-6A0A-4CD7-97F0-802ECD04D2E0Q36496342-F61712E2-D5F5-4FF3-AE85-D1054B1CFA00Q36519765-8C6FBB00-3C27-4BDE-852B-16346ACCABB6Q36749103-8FC5E982-657F-4C67-A4E0-E6585D1CE615Q36752100-C811BFFF-A805-49B9-94B0-430C379FB181Q37558108-D058CF7D-D69B-4D06-9345-BAA6EFAF8910Q37594434-F73ACBD9-2A42-4275-B048-6B0F8E8AAE1EQ37662795-2418ED8F-CB7F-47F5-929F-E210DE9DE2ADQ38042312-9DB861AB-D067-43C5-A8E1-93CBD6AF35F5Q38232998-D60FB787-B46F-4AF1-A474-C7878C3ED02EQ39938314-CADC3A07-EF28-4558-8F86-DD8C67DE7EF8Q39999043-350D60F5-E2FA-40B2-9234-BFA1F66A46A7Q40744842-A7CC8997-74B2-4691-B032-E5DDFC381A21Q41998884-AC07D4F5-9235-43DF-8482-B6683DA6CD78Q43172100-E53328C6-CE82-4500-B33F-A792D37F8F22Q43740465-D13FA424-B849-48CB-9C98-EE9E3C117D58Q43989979-5291ACAF-2649-4C07-B3F7-FC911ED68B0BQ44075468-50A58735-77CD-4375-BE9F-4E91E0700C4CQ44198842-6A4532A6-F9AF-4847-BC2A-D796A3C6D261Q44650981-8F7FCBF0-FF76-40CF-A86D-2590E9B1BC53Q44724706-E20D8F03-04F5-46B7-A39C-3459FFB3875DQ44872751-97FF6649-4FDA-4CF3-B2A7-53E0EC5FAC9BQ45059448-30CFDBCD-70F7-4326-A85A-24C243F3089DQ45873233-03600871-349E-4C99-901E-CA4A21ECF59DQ46395823-4434EC9E-1622-4140-A174-0A3793677C13Q46471567-8B5D481F-A887-4C56-A2E5-EA81F3701EE5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jason Lee Johnson
@ast
Jason Lee Johnson
@en
Jason Lee Johnson
@es
Jason Lee Johnson
@nl
Jason Lee Johnson
@sl
type
label
Jason Lee Johnson
@ast
Jason Lee Johnson
@en
Jason Lee Johnson
@es
Jason Lee Johnson
@nl
Jason Lee Johnson
@sl
prefLabel
Jason Lee Johnson
@ast
Jason Lee Johnson
@en
Jason Lee Johnson
@es
Jason Lee Johnson
@nl
Jason Lee Johnson
@sl
P214
P244
P106
P1153
8244663800
P21
P214
P244
nb2010006433
P31
P496
0000-0003-0630-9183
P734
P735
P7859
lccn-nb2010006433